利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

658 条记录 (耗时 0.027 秒)

    Agent for preventing and treating deafness
    91.
    发明专利
    Agent for preventing and treating deafness 审中-公开
    防止和处理复合材料的代理

    公开(公告)号：JP2004099537A

    公开(公告)日：2004-04-02

    申请号：JP2002264418

    申请日：2002-09-10

    申请人： Sanwa Kagaku Kenkyusho Co Ltd ,  株式会社三和化学研究所

    发明人： KUBO TAKESHI ,  DOI KATSUMI ,  NANBA TOSHIHIKO ,  NAGANO HIROSHI

    IPC分类号： A61K38/43 ,  A61K35/39 ,  A61P27/16

    摘要： PROBLEM TO BE SOLVED: To provide an agent for preventing and treating deafness, especially inner ear deafness based on a new concept. SOLUTION: The agent for preventing and treating the deafness, especially the inner ear deafness contains kallidinogenase, e.g. the kallidinogenase derived from the swine pancreas as an active ingredient. COPYRIGHT: (C)2004,JPO

    摘要翻译： 要解决的问题：提供一种用于预防和治疗耳聋的药剂，特别是基于新概念的耳内耳聋。 解决方案：用于预防和治疗耳聋的药物，特别是内耳聋包含杀鼠肽素酶 衍生自猪胰腺的杀鼠idin素酶作为活性成分。 版权所有（C）2004，JPO

    Composition for anagenesis
    92.
    发明专利
    Composition for anagenesis 审中-公开
    用于分析的组合物

    公开(公告)号：JP2004075547A

    公开(公告)日：2004-03-11

    申请号：JP2002233790

    申请日：2002-08-09

    申请人： Jms Co Ltd ,  Rui Yuge ,  弓削 類 ,  株式会社ジェイ・エム・エス

    发明人： MATSUURA YOJI ,  YUGE RUI

    IPC分类号： A61K9/10 ,  A61K35/12 ,  A61K35/23 ,  A61K35/30 ,  A61K35/32 ,  A61K35/34 ,  A61K35/39 ,  A61K35/407 ,  A61K35/54 ,  A61K47/34 ,  A61K47/36 ,  A61K47/42 ,  A61L27/00 ,  A61L31/00 ,  A61P43/00

    摘要： PROBLEM TO BE SOLVED: To provide a cell-containing composition which can simply be used for a cell transplantation treatment without needing a complicated operation such as the peeling of cells and the processing and formation of a scaffold and can exclude an adverse effect to the cells as mush as possible, when transplanted. SOLUTION: This composition for anagenesis is characterized by comprising microparticles formed from a flowable medium and a bioabsorbable material floated in the flowable medium and cells adhered to the surfaces of the microparticles, wherein the whole composition has flowability. Since the cells are proliferated or differentiated into target cells on the surfaces of the microparticles, the cells maintain flowability together with the microparticles, and can, as such, be injected and transplanted in a living body. Thereby, the complicated operation such as the peeling of cells and the processing and formation of a scaffold can be excluded, and the adverse effect on the cells can also be avoided. COPYRIGHT: (C)2004,JPO

    摘要翻译： 要解决的问题：提供可以简单地用于细胞移植治疗的细胞含有组合物，而不需要复杂的操作，例如细胞的剥离和支架的加工和形成，并且可以排除不利影响 移植到细胞尽可能糊状。 解决方案：用于成像的组合物的特征在于包含由可流动介质和悬浮在可流动介质中的生物可吸收材料形成的微粒和粘附到微粒表面的细胞，其中整个组合物具有流动性。 由于细胞增殖或分化成微粒表面上的靶细胞，所以细胞与微粒一起保持流动性，并且因此可以注射并移植到生物体中。 因此，可以排除诸如细胞剥离和支架的加工和形成等复杂的操作，并且还可以避免对细胞的不利影响。 版权所有（C）2004，JPO